Back to Search
Start Over
Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.
- Source :
-
Viruses [Viruses] 2020 Dec 13; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 13. - Publication Year :
- 2020
-
Abstract
- Acyclovir is the drug of choice for the treatment of herpes simplex virus (HSV) infections. Acyclovir-resistant HSV strains may emerge, especially during long-term drug use, and subsequently cause difficult-to-treat exacerbations. Previously, we set up a novel treatment approach, based on enzymatically synthesized pools of siRNAs, or siRNA swarms. These swarms can cover kilobases-long target sequences, reducing the likelihood of resistance to treatment. Swarms targeting the UL29 essential gene of HSV-1 have demonstrated high efficacy against HSV-1 in vitro and in vivo. Here, we assessed the antiviral potential of a UL29 siRNA swarm against circulating strains of HSV-1, in comparison with acyclovir. All circulating strains were sensitive to both antivirals, with the half-maximal inhibitory concentrations (IC <subscript>50</subscript> ) in the range of 350-1911 nM for acyclovir and 0.5-3 nM for the UL29 siRNA swarm. Additionally, we showed that an acyclovir-resistant HSV-1, devoid of thymidine kinase, is highly sensitive to UL29 siRNA treatment (IC <subscript>50</subscript> 1.0 nM; I <subscript>max</subscript> 97%). Moreover, the detected minor variations in the RNAi target of the HSV strains had no effect on the potency or efficacy of UL29 siRNA swarm treatment. Our findings support the development of siRNA swarms for the treatment of HSV-1 infections, in order to circumvent any potential acyclovir resistance.
- Subjects :
- Acyclovir therapeutic use
Animals
Chlorocebus aethiops
Dose-Response Relationship, Drug
Drug Resistance, Viral drug effects
Drug Resistance, Viral genetics
Herpes Simplex therapy
Herpesvirus 1, Human classification
Herpesvirus 1, Human isolation & purification
Humans
Inhibitory Concentration 50
Vero Cells
Acyclovir pharmacology
DNA-Binding Proteins genetics
Herpes Simplex virology
Herpesvirus 1, Human drug effects
Herpesvirus 1, Human genetics
RNA Interference
RNA, Small Interfering genetics
Viral Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1999-4915
- Volume :
- 12
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Viruses
- Publication Type :
- Academic Journal
- Accession number :
- 33322225
- Full Text :
- https://doi.org/10.3390/v12121434